Sidley’s global Food, Drug and Medical Device practice represents major biopharmaceutical, biotechnology, medical device, food, cosmetic, dietary supplement, and consumer technology companies worldwide. We have a particular focus on novel therapies and technologies, digital health, and cell and gene therapy. Our premier, destination practice partners with clients at every stage of growth, from startups to Fortune 10 companies, and throughout the product lifecycle, from development and clinical trials to post-marketing and critical compliance and enforcement issues.
We leverage deep understanding of the life sciences industry and regulators to devise sophisticated engagement strategies involving government regulators such as U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), European Commission, and China’s National Medical Products Administration (NMPA); help companies navigate important contentious and non-contentious proceedings; and advise on complex life sciences deals, litigation, and investigations. Our clients trust the Sidley Food, Drug and Medical Device team to deliver because of our wealth of knowledge and experience in delivering targeted and innovative solutions to novel problems.
FDA Law Firm of the Year
U.S. News – Best Lawyers “Best Law Firms” Survey 2022